» Authors » Madhusudhan Reddy

Madhusudhan Reddy

Explore the profile of Madhusudhan Reddy including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 17
Citations 67
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Reddy M, Moturi K, Sunil V, Koneru M, Raj G
Cureus . 2024 Oct; 16(9):e69496. PMID: 39416544
A dentinogenic ghost cell tumor (DGCT) is a rare and locally aggressive benign mixed odontogenic tumor, histologically made up of ameloblast-like epithelial islands, ghost cells, and dentin-like material. This is...
2.
Ganeshkumar P, Ilangovan K, Jagadeesan M, Reddy M, Vidhya F, Vairamani V, et al.
Glob Health Sci Pract . 2023 Feb; 11(1). PMID: 36853628
During the early months of the COVID-19 pandemic in 2020, the majority of the identified COVID-19 patients in Chennai, a southern metropolitan city of India, presented as asymptomatic or with...
3.
Verma M, Samant C, Kale R, Patra S, Mahajan N, Gholve M, et al.
Biochem Biophys Res Commun . 2022 Nov; 637:267-275. PMID: 36410276
Phosphoinositide 3-kinase (PI3K) pathway mediates key signaling events downstream to B-cell receptor (BCR) for survival of mature B-cells, and overexpression or overactivation of PI3Kδ is crucial for B-cell malignancies such...
4.
Kanoje V, Pandey D, Wagh A, Patra S, Kumar Marisetti A, Reddy M, et al.
Eur J Pharmacol . 2022 May; 927:175054. PMID: 35636524
PI3Kδ plays a critical role in adaptive immune cell activation and function. Suppression of PI3Kδ has been shown to counter excessive triggering of immune responses which has led to delineating...
5.
M J, Ganeshkumar P, Kaur P, Sriramulu H, Sakthivel M, Rubeshkumar P, et al.
BMJ Open . 2022 Mar; 12(3):e052067. PMID: 35288381
Objectives: To describe the public health strategies and their effect in controlling the COVID-19 pandemic from March to October 2020 in Chennai, India. Setting: Chennai, a densely populated metropolitan city...
6.
Karumanagoundar K, Raju M, Ponnaiah M, Kaur P, Viswanathan V, Rubeshkumar P, et al.
BMJ Open . 2021 Nov; 11(11):e051491. PMID: 34740930
Objective: To describe the characteristics of contacts of patients with COVID-19 case in terms of time, place and person, to calculate the secondary attack rate (SAR) and factors associated with...
7.
M J, Rubeshkumar P, Raju M, Sakthivel M, Murali S, Nagarajan R, et al.
PLoS One . 2021 Sep; 16(9):e0257739. PMID: 34559845
Purpose: Government of Tamil Nadu, India, mandated the face mask wearing in public places as one of the mitigation measures of COVID-19. We established a surveillance system for monitoring the...
8.
Shukla M, Patra S, Verma M, Sadasivam G, Jana N, Mahangare S, et al.
J Med Chem . 2020 Dec; 63(23):14700-14723. PMID: 33297683
PI3Kδ inhibitors have been approved for B-cell malignancies like CLL, small lymphocytic lymphoma, and so forth. However, currently available PI3Kδ inhibitors are nonoptimal, showing weakness against at least one of...
9.
Rao A, Reddy M, Mahanthi V, Venkata Chalapathi K
J Cancer Res Ther . 2019 Jun; 15(3):715-718. PMID: 31169249
Ameloblastic fibro-odontoma (AFO) is a benign, epithelial odontogenic tumor with odontogenic mesenchyme having the histologic characteristics of both ameloblastic fibroma and complex odontoma. This report describes the case of a...
10.
Chaitanya P, Martha S, Punithvathy R, Reddy M
Int J Clin Pediatr Dent . 2018 Aug; 11(3):244-246. PMID: 30131649
Most of the lesions in the oral cavity have papillary appearance. Oral squamous papilloma (SP) is one such type, which is a benign proliferation of the stratified squamous epithelium and...